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Background: The etiology of the metabolic syndrome is complex, and is determined by the interplay of both
genetic and environmental factors. The present study was designed to identify genes and proteins in the adipose
tissues with altered expression in the spontaneously hypertensive/NIH –corpulent rat, SHR/NDmcr-cp (CP) and to
find possible molecular targets associated with the pathogenesis or progression of obesity related to the metabolic
syndrome.
Methods: We extracted RNAs and proteins from the epididymal adipose tissues in CP, SHR/Lean (Lean), and Wistar
Kyoto (WKY) rats and performed microarray analysis and two-dimensional difference in gel electrophoresis (2D-DIGE)
linked to a matrix-assisted laser desorption ionization time-of-flight tandem mass spectrometry (MALDI-TOF/TOF MS).
Results: The results showed different mRNA and protein expression levels in the adipose tissue: oligo DNA
microarray identified 33 genes that were significantly (P < 0.01) up-regulated and 17 genes significantly down-
regulated in CP compared with WKY and Lean rats at both 6 and 25 weeks of age. The affected genes-proteins
were associated with lipolytic enzymes stimulated by peroxisome proliferator-activated receptor (PPAR) signaling.
Further analysis using the 2D-DIGE connected with MALDI-TOF/TOF analysis, the expression of monoglyceride lipase
(MGLL) was significantly up-regulated and that of carboxylesterase 3 (CES3) was significantly down-regulated in
6- and 25-week-old CP compared with age-matched control (WKY and Lean rats).
Conclusions: Our results suggest the possible involvement of proteins associated with adipocyte lipolysis in obesity
related to the metabolic syndrome.
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Obesity is currently an important public health problem
worldwide [1]. Many overweight individuals suffer vari-
ous metabolic abnormalities such as dyslipidemia, hyper-
tension, and abnormal glucose tolerance associated with
insulin resistance [2,3]. Moreover, the cardiometabolic* Correspondence: saho@gene.mie-u.ac.jp
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reproduction in any medium, provided the orrisk in overweight and obese adults need to be reduced
through both clinical and public health programs [4].
Evidence suggests that excessive adipose tissue worsens
morphologic and dynamic cardiac function and induces
cardiac abnormalities due to neurohormonal activation
and increased cytokine production [5,6].
It is difficult to study the mechanisms of the metabolic
syndrome in humans due to the involvement of hetero-
geneous genetic background and lifestyle. The spontan-
eously hypertensive rat/NDmcr-cp (SHR/NDmcr-cp) is a
new genetically obese strain that develops hyperten-
sion, hyperlipidemia, and insulin-independent diabetesLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the SHR, which carry nonsense mutation of leptin re-
ceptor, which is derived from obese Koletsky rats [8].
Obese SHR/NDmcr-cp show morbid obesity compared
with the lean littermates. Since the phenotype of SHR/
NDmcr-cp is similar to that seen in patients with the
metabolic syndrome, SHR/NDmcr-cp are thought to be
one of the most suitable animal models of the metabolic
syndrome [9].
DNA microarray analysis is not only a useful strategy
for the identification of functional genes in several
model organisms [10], but also considered as a powerful
tool to visualize the molecular mechanism underlying
complex biological processes [11]. In addition, the field
of proteomics provides a systematic approach for quanti-
tative and qualitative mapping of the whole proteome
[12]. Proteomics analysis is used to complete comple-
ment of proteins expressed by a biological system under
different physiological or pathological conditions [13].
Given that examining changes in the proteome offers
insight into cellular and molecular mechanisms that can-
not always be obtained through genomic analysis, we
performed DNA microarray and proteomics analyses
simultaneously to investigate changes in gene and pro-
tein profiles.
The adipose tissue secretes a number of proteins, in
addition to being source of energy in the body [14]. In
the present study, we investigated changes in the expres-
sion of genes and proteins in adipose tissues in an ani-
mal model of the metabolic syndrome to find possible




SHR/NDmcr-cp (CP), SHR/Lean (Lean), and Wistar
Kyoto (WKY) rats were purchased from the Disease
Model Cooperative Research Association (Kyoto, Japan)
[15]. In our previous study, CP exhibited obesity, hyper-
tension, and dyslipidaemia, including hypercholesterol-
aemia, at a young age and presented all the features of
the metabolic syndrome such as central obesity, hyper-
glycaemia, hypercholesterolaemia, hypertriglyceridaemia,
hypertension, and insulin resistance beyond the 24
weeks of age [16]. In the present study, we used CP at 6
weeks of age as a model for the early stage of the meta-
bolic syndrome and at 25 weeks of age as a model for
the chronic stages of the metabolic syndrome. The
animals were fed normal diet and housed at a temperature-
controlled (25°C) environment with a 12-hour light–
dark cycle. The investigation conformed to the Guide
for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH
Publication No. 85–23, revised 1996) and was approvedby the Committee on Laboratory Animals Utilization of
Mie University.
Measurements of blood pressure and biochemical tests
Systolic blood pressure was measured in conscious rats
by the tail-cuff method as described previously [17].
Blood was collected from anesthetized rats, transferred
to a chilled tube containing heparin, and centrifuged.
Plasma was stored at −80°C until analysis. Serum levels
of triglyceride, total cholesterol, and glucose were out-
sourced to SRL (Tokyo, Japan).
Preparation of RNA
Epididymal adipose tissue was obtained from 6 or 25
week old rats and frozen immediately in liquid nitrogen
and stored at −80°C. Total RNA was extracted from
about 250 mg of epididymal adipose tissue using the
RNeasy Lipid Tissue Mini Kit (Qiagen, Valencia, CA), ac-
cording to the instructions provided by the manufacturer.
The concentration of the total RNA was quantified by
spectrophotometry (ND-1000, NanoDrop Technologies,
Wilmington, DE). The expression level was evaluated
on an oligo nucleotide microarray (Whole Rat Genome
microarray 22 K, Agilent Technologies, Santa Clara, CA)
in 1) CP and WKY at 6 weeks of age, 2) CP and Lean
at 6 weeks of age, 3) CP and WKY at 25 weeks of age,
and 4) CP and Lean at 25 weeks of age. Two microarray
slides were used for each comparison between two groups
in two different RNA samples from three different rats
per group.
Hybridization, microarray scanning, and data analysis
The reverse transcription labeling and hybridization
were conducted using the Agilent 60-mer Oligo microarray
(Agilent Technologies), according to the instructions pro-
vided by the manufacturer. After hybridization, the glass
slides were scanned with an Agilent DNA MicroArray
Scanner (Agilent Technologies) containing a 532 nm laser
for Cy3 measurement and a 635 nm laser for Cy5 measure-
ment. Microarray data analysis was carried out using
GeneSpring ver. 7.3.1 software (Agilent Technology) [18].
The detected signals were subjected to normalization using
GeneSpring normalization algorithms. In each compari-
son, genes were filtered based on minimum ±1.0 of log
ratio (WKY vs. CP or Lean vs. CP) and P < 0.01 using the
Student’s t-test. Gene Ontology (GO) analysis was per-
formed using GeneSpring (Agilent Technology).
Protein samples preparation and separation by
two-dimensional fluorescence difference gel
electrophoresis (2D-DIGE) and data analysis
Frozen tissue sections were homogenized in lysis buffer
(30 mM Tris–HCl, 7 M urea, 2 M thiourea, 4% w/v CHAPS,
and a protease inhibitor cocktail, pH 8.5). Protein extracts
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the same two-dimensional (2D) gel. The epididymal
adipose tissue mixture was labeled with Cy2 for the use
as an internal standard for every gel electrophoresis and
2DE was performed as described previously [19]. Images
were visualized using Typhoon 9400 fluorescence scanner
(GE Healthcare, Buckinghamshire, UK) at 488/520 nm for
Cy2, 532/580 nm for Cy3 and 633/670 nm for Cy5 dyes.
The differential in-gel analysis module of the DeCyder
software (GE Healthcare) was used for automatic detec-
tion followed by editing of protein spots. The same soft-
ware was used for abundance measurements for each gel
by comparing normalized volume ratios of individual
spots from Cy3- or Cy5-labeled samples to corresponding
Cy2-signals from pooled samples (internal standard) [15].
Thereafter, all gel comparisons and initial screening type
statistical analyses were performed with the biological
variation analysis module. Two-tailed Student’s t-test was
used to determine differences between paired groups
(WKY vs. CP or Lean vs. CP) using this module.Protein identification
After image analysis, gels containing the additional load
of unlabeled proteins from the epididymal adipose tissue
were stained with Colloidal Coomassie Brilliant Blue G
(GE Healthcare) and matched to the fluorescent 2D-
DIGE images. Selected spots were picked and in-gel di-
gestion of protein samples was performed using the
protocol described previously by our group [15]. The pep-
tide mixtures were analyzed using matrix-assisted laser
desorption ionization time-of-flight tandem mass spec-
trometry (MALDI-TOF/TOF MS; 4800 Plus MALDI
TOF/TOF™ Analyzer, Applied Biosystems, Foster City,
CA) operating in positive-ion reflector mode. Protein
database search was performed with the Paragon Method
using Protein Pilot software (Applied Biosystems) to iden-
tify excised proteins.Quantitative RT-PCR
To confirm the gene expression of identified proteins,
total RNA extracted from the adipose tissue (n = 6 in
each group) was subjected to quantitative reverse tran-
scription and polymerase chain reaction (RT-PCR) ana-
lysis with primers specific for mRNAs encoding serine
protease inhibitor A3L (Spin2b), alpha-2-HS-glycopro-
tein (Ahsg), carboxylesterase 3 (Ces3), monoglyceride lip-
ase (Mgll), and pyruvate dehydrogenase E1 component
subunit beta (Pdhd1), using ABI PRISM 7000 Sequence
Detection System (Applied Biosystems). All primers and
FastStart Universal Probes were designed from the Assay
Design Center/Probe Finder (Roche Applied Science,
Indianapolis, IN). Standard curves were generated for
each primer set and a coefficient file generated to quantifythe expression of each gene relative to β-actin. All experi-
ments were performed in duplicates.
Western blot analysis
To confirm the results of proteomic analysis, western
blot analysis was conducted. For this purpose, samples
(n = 4 or 6 in each group) were separated by 12% SDS-
PAGE and electroblotted onto polyvinylidenedifluoride
(PVDF) membranes. The membranes were incubated
with goat polyclonal antibodies to rat AHSG (Santa Cruz
Biotechnology, Santa Cruz, CA) at a 1:10,000 dilution and
to human CES3 (Santa Cruz Biotechnology) at a 1:10,000
dilution, and a rabbit polyclonal antibody to MGLL
(Abcam, Cambridge, UK) at a 1:5,000 dilution. Mouse anti-
β-actin (ACTB) monoclonal antibody (Sigma, St Louis,
MO) at a 1:5,000 dilution was used as a loading control.
The protein bands were visualized by ECL plus Western
blotting detection system (GE Healthcare) and Quantity
One v3.0 software (Bio-rad Laboratories) was used to quan-
titate the band intensities. Protein expression levels were
normalized relative to the level of β-actin protein in the
same tissue sample.
Statistical analysis
Data are presented as mean ± SEM. Regarding the
physiological and biochemical parameters and quantitated
data by both RT-PCR and western blot analyses, statistical
significance was evaluated by one-way analysis of variance
followed by Dunnett’s post hoc test using the JMP 8.0 soft-
ware (SAS Institute Inc., Cary, NC). A P value <0.05 was
considered statistically significant.
Results
Body weight, epididymal adipose tissue weight, systolic
blood pressure, and plasma biochemical data
Body weight and epididymal adipose tissue weight of 6-
and 25-week-old CP rats were significantly greater than
age-matched WKY and Lean rats (Figure 1A, B). There
were no significant differences between WKY and Lean
rats at both 6 and 25 weeks of age. Hypertension was
observed in both CP and Lean rats aged 6 and 25 weeks,
and there was no significant difference in systolic blood
pressure between the two strains (data not shown).
At 6 weeks of age, there were no significant differ-
ences in triglyceride and non-fasting glucose levels among
the three groups (Figure 1C, D). At 25 weeks of age, the
plasma levels of triglyceride and non-fasting glucose were
significantly higher in CP than in WKY and Lean rats
(Figure 1C, D).
Microarray analysis of gene expression profiles
After the experiments of microarray analysis, all hybridization
spots on the image were quantified. The intensity of fluor-
escence of data was converted into Log10 values and
Figure 1 Body weight and plasma biochemical data. (A) Body weight, (B) epididymal adipose tissue weight, and plasma levels of (C) triglyceride
and (D) non-fasting glucose in WKY, Lean, and CP rats at 6 and 25 weeks of age. Data are mean ± SEM of six animals per group. *P < 0.05, versus the
corresponding value for WKY. WKY; Wistar Kyoto rats, Lean; spontaneously hypertensive rats (SHR/lean), CP; SHR/NDmcr-cp (cp/cp) rats.
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analyzed the extracted data and obtained the genes that
showed significant differences between CP and WKY or
Lean rats. On the oligo DNA microarray, 535 or 318 genes
were significantly up-regulated (p < 0.01) in 6-week-old
CP compared with age-matched WKY and Lean rats, re-
spectively. Furthermore, 508 and 446 genes were down-
regulated in 6 weeks-old CP compared with WKY or Lean
rats of the same age, respectively. In 25-week-old rats,
significant up-regulation of 277 and 286 genes, and down-
regulation of 224 and 638 genes were noted in CP com-
pared with WKY and Lean rats, respectively. Moreover, 33
genes were significantly up-regulated and 17 genes were
significantly down-regulated in the epididymal adipose tis-
sues of CP compared with WKY and Lean rats at both 6
and 25 weeks of age (Additional file 1: Tables S1 and S2).
To understand their biological roles, the genes with signifi-
cantly different expression levels by microarray analysis were
assigned to established GO classification by GeneSpring
ver.7.3.1. In GO classification, three aberrant GO terms
(p < 0.01) were found in up-regulated genes in CP com-
pared with WKY and Lean rats at both 6 and 25 weeks of
age; transferases, electron transport, and electron trans-
porter activity (Table 1). Based on the Kyoto Encyclopedia
of Genes and Genomes (KEGG) molecular pathway ana-
lysis, genes with significantly different expression levels by
microarray analysis were also assigned to KEGG molecular
pathway by GeneSpring. The analysis identified 5 pre-
dicted pathways for the up-regulated genes in CP com-
pared with WKY and Lean rats at both 6 and 25weeks of age. These included peroxisome proliferator-
activated receptor (PPAR) signaling pathway, carbon
fixation, pentose phosphate pathways, glutathione me-
tabolism, and alkaloid biosynthesis I (Table 1).
Comparison of protein identification
To investigate differences in protein expression in the adi-
pose tissues, epididymal adipose tissue proteins from 6-
and 25-week-old WKY, Lean, and CP rats were extracted
and subjected to comparative analysis by DIGE. Typical
gels are shown in Figure 2A. Seven spots in the 2-DE gels
were significantly different in 6- and 25-week-old CP, WKY
and Lean rats. These spots were isolated and subjected to
MALDI-TOF-MS. The peptides mass peaks were com-
pared with those in the NCBI database and the proteins of
the seven spots were identified (Table 2). The expression
levels of proteins of spots 1580 and 1584 were significantly
up-regulated while those of spots 827, 845, 855, 988, and
1662 were significantly down-regulated in CP compared
with WKY and Lean rats at both 6 (Figure 2B) and 25
weeks of age (Figure 2C). The identified proteins were
serine protease inhibitor A3L (Spin2b) (spot 827), alpha-2-
HS-glycoprotein (AHSG) (spots 845 and 855), carboxyles-
terase 3 (CES3) (spot 988), monoglyceridelipase (MGLL)
(spots 1580 and 1584), and pyruvate dehydrogenase E1
component subunit beta (PDHB1) (spot 1662).
Expression of identified proteins
The gene expression levels of the five identified proteins
were confirmed by quantitative RT-PCR analysis. At 25
Table 1 List of entities identified by GO and the pathways identified by KEGG of significantly up-regulated and
down-regulated genes in adipose tissues of 6- and 25-week-old CP rats
GO accession GO term
P value
6-week-old 25-week-old
WKY-CP Lean-CP WKY-CP Lean-CP
Up-regulation
GO:0016740 Transferase 1.4E-14 2.0E-08 6.8E-06 4.4E-06
GO:0006118 Electron transport 8.0E-08 4.1E-03 3.6E-03 1.7E-04
GO:0005489 Electron transporter activity 2.6E-07 1.0E-02 3.7E-03 1.6E-04
Down-regulation
GO:0016740 Transferase 5.43E-02 3.49E-03 2.68E-04 1.41E-11
GO:0005489 Electron transporter activity 1.09E-01 1.26E-03 1.71E-02 1.80E-05
GO:0006118 Electron transport 1.11E-01 1.30E-03 1.73E-02 1.87E-05
Predicted pathway
Up-regulation
PPAR signaling pathway 4.25E-11 2.71E-03 9.73E-03 5.54E-02
Carbon fixation 4.50E-07 1.10E-05 2.33E-03 3.11E-02
Pentose phosphate pathway 2.84E-05 1.45E-03 3.92E-05 1.90E-01
Glutathione metabolism 2.14E-04 4.55E-03 1.95E-04 2.21E-04
Alkaloid biosynthesis I 9.47E-03 1.00E + 00 2.62E-03 2.79E-03
Down-regulation
ECM-receptor interaction 7.40E-04 1.64E-02 1.09E-02 3.85E-03
Glycolysis _ Gluconeogenesis 1.59E-03 4.60E-04 5.56E-02 1.42E-01
Fructose and mannose metabolism 3.09E-03 1.12E-03 3.01E-02 3.80E-01
Cell Communication 9.95E-03 2.64E-03 4.71E-02 5.18E-02
Carbon fixation 8.65E-02 4.63E-04 1.27E-03 4.82E-04
WKY; Wistar Kyoto rats, Lean; spontaneously hypertensive rats (SHR/lean), CP; SHR/NDmcr-cp (cp/cp) rats.
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significantly greater while those of Spin2b and CES3
were significantly lower in CP compared with age-
matched WKY rats (Figure 3). Western blot analysis was
also performed to confirm the results of proteomics analysis.
The expression of MGLL was significantly up-regulated
while that of CES3 was significantly down-regulated in
6-and 25-week-old CP compared with age-matched con-
trol (WKY and Lean rats) (Figure 4). These findings were
consistent with those of proteomic analysis.
Discussion
In the present study, we performed genomic and prote-
omic analyses to identify the target molecules associated
with obesity related to the metabolic syndrome. More
than one thousand genes were significantly different in
the microarray analysis and many hundred proteins were
significantly different in the proteomic analysis among the
three rat groups at 6 or 25 weeks of age. Among them,
microarray analysis identified 33 significantly up-regulated
genes and 17 significantly down-regulated genes in adi-
pose tissues of 6- and 25-week-old CP, compared withage-matched WKY and Lean rats. Proteomics analysis
identified significantly different five proteins in CP than
WKY and Lean rats at both 6 and 25 weeks of age. Only a
few of the genes showed similar changes both in the
microarray and the proteomics analysis. Previous studies
using transcriptomic and proteomics analyses demon-
strated a positive correlation between transcript and pro-
tein levels for the majority of molecules [20], but other
studies reported limited correlation between transcription
and translation in mammals [21]. The different expression
patterns noted in the two methodological approaches
might arise from limitation of detection sensitivity or elec-
trophoretic separation. Moreover, the discrepancy be-
tween the microarray and proteomics analyses might be
due to differential regulation of translation, turnover, or al-
ternative splicing.
With the gene-by-gene approach, it would be difficult
and time-consuming to obtain a global picture of gene
expression patterns. The cDNA and oligo array technol-
ogy allows simultaneous comparison of thousands of
mRNAs from a given tissue, and thus provides a compre-
hensive assessment of expression levels. So far, microarray
Figure 2 Representative 2D-DIGE image of adipose lysates from 25-week-old Lean and CP rats. (A) The proteins (40 μg each) were
labeled with Cy3 and Cy5 dyes, mixed and subjected to 2D-DIGE analysis. We selected significantly different spots of 6- and 25-week-old CP
compared with age-matched control (WKY and Lean) rats. The expression level was quantified in each strain at 6 (B) and 25 weeks of age
(C) and expressed as mean ± SEM of four rats per group. *P < 0.05, versus the corresponding value for WKY or Lean rats. WKY; Wistar Kyoto rats,
Lean; spontaneously hypertensive rats (SHR/lean), CP; SHR/NDmcr-cp (cp/cp) rats.
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field [22,23]. In the present study, we applied comparative
genomic and proteomic analyses of adipose tissue to iden-
tify the molecular targets associated with obesity related
to the metabolic syndrome. Microarray analysis identifiedTable 2 List of proteins with significant differences in their le
CP, WKY, and Lean rats
Spot Protein name
% cov.
827 Serine protease inhibitor A3L 12.1
845 Alpha-2-HS-glycoprotein 10.5
855 Alpha-2-HS-glycoprotein 10.5
988 Carboxylesterase 3 11
1580 Monoglyceride lipase 21.8
1584 Monoglyceride lipase 20
1662 Pyruvate dehydrogenase E1 component subunit β 31.8
Abbreviations as in Table 1.33 significantly up-regulated genes and 17 significantly
down-regulated genes in the epididymal adipose tissues of
CP compared with WKY and Lean rats at both 6 and 25
weeks of age. Among them, only CES3 showed significant





WKY-CP Lean-CP WKY-CP Lean-CP
4 −1.74 −1.6 −3.74 −4.12
3 −1.9 −1.17 −3.98 −3.4
3 −1.71 −1.56 −3.17 −3.33
5 −1.89 −1.53 −2.9 −3.4
6 2.26 2.45 1.89 1.64
2 1.77 2.08 1.79 1.63
5 −1.39 −1.31 −1.44 −1.53
Figure 3 Gene expression of the identified proteins in WKY, Lean, and CP rats at 6 and 25 weeks of age. The mRNA levels of Spin2b,
AHSG, CES3, MGLL, and PDHB1 in the adipose tissues were determined by quantitative RT-PCR analysis and expressed relative to that of β-actin.
Quantitative data are expressed relative to the values for WKY. Data are mean ± SEM of six animals per group. *P < 0.05, versus the corresponding
value for WKY. WKY; Wistar Kyoto rats, Lean; spontaneously hypertensive rats (SHR/lean), CP; SHR/NDmcr-cp (cp/cp) rats.
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hydrolase, is an endoplasmic reticulum lipase which be-
longs to the type-B carboxylesterase/lipase family [24].
These carboxylesterases are responsible for the hydrolysis
of ester- and amide-bond-containing drugs, such as co-
caine and heroin, and are involved in the detoxification of
xenobiotics and activation of ester and amide prodrugs
[25]. CES3 is highly expressed in the liver, adipose tissue
and also expressed in the small intestine, heart, and kidneyFigure 4 The amounts of AHSG, CES3, and MGLL in WKY, Lean, and C
each protein. (B) The amount of each protein quantitated relative to the am
mean ± SEM of six animals per group. *P < 0.05, versus the corresponding v
hypertensive rats (SHR/lean), CP; SHR/NDmcr-cp (cp/cp) rats.[26]. The specific function of this enzyme has not yet been
determined; however, it is speculated that carboxyles-
terases may play a role in lipid metabolism because
endobiotics, such as triglyceride, cholesterol esters, and 2-
arachidonoylglycerol are also substrates for carboxyles-
terases [27,28]. Given that carboxylesterases hydrolyzes
long-chain fatty acid esters and thioesters, these enzymes
have been considered therapeutic targets in the treatment
of metabolic disorders, such as diabetes and atherosclerosisP rats at 6 and 25 weeks of age. (A) Representative immunoblots of
ount of β-actin and expressed relative to the value of WKY. Data are
alue for WKY. WKY; Wistar Kyoto rats, Lean; spontaneously
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nificantly down-regulated in the adipose tissue of CP com-
pared with WKY and Lean rats at the two tested ages.
These results suggest that a decrease in lipolytic enzyme
activity could affect the hydrolysis of triglyceride to fatty
acids and glycerol, leading to its accumulation in adipose
tissue. In a study using CES3 knockout mice, global de-
letion of CES3 resulted in significant decreases in plasma
triglyceride and fatty acid levels although the weight of white
adipose tissue was greater in CES3 knockout mice com-
pared with wild-type mice [30]. Moreover, CES3 knockout
mice showed the improvement of insulin sensitivity and glu-
cose tolerance. Since CP rats were hyperglycemic and
hyperinsulinemic, the lipid profiles in our CP rats are dif-
ferent from those of the CES3 knockout mice. Taken to-
gether with the results of these previous studies, CES3
might be down-regulated in CP rats as a result of hyper-
glycemia or physiological adaptation to obesity.
In the present study, MGLL was up-regulated in adi-
pose tissues of CP compared with age-matched controls.
Adipose tissue triglycerides are likely hydrolyzed in a
three-step process catalyzed by adipose triglyceride lip-
ase, hormonesensitive lipase, and MGLL [31]. MGLL is
a glyceride consisting of one fatty acid chain covalently
bonded to a glycerol molecule through an ester linkage
[32]. MGLL hydrolyzes monoglyceride to free glycerol
and fatty acid, and is considered the rate-limiting step of
monoglyceride hydrolysis in mammals [33]. A previous
study showed that whole-body MGLL knockout mice ex-
hibited decreased forskolin-stimulated fatty acid and gly-
cerol release from white adipose tissues and attenuated
high-fat diet-induced insulin resistance [34]. Given that
augmented fatty acid release in the basal condition caused
by increased lipolytic enzymes is implicated in the devel-
opment of insulin resistance of adipocytes, up-regulation
of MGLL in CP rats may contribute to the pathogenesis or
progression of obesity related to the metabolic syndrome.
It is known that perilipins (e.g. perilipin 1) and other li-
pases, such as hormone-sensitive lipase and adipose trigly-
ceride lipase are also pivotal in the regulation of adipose
tissue fat metabolism. However, there were no significant
differences in the expression of these lipases, between CP
and control (WKY and Lean rats) at 6 or 25 weeks of age.
In the present microarray analysis, KEGG annotation
revealed significant differences in proteins associated
with the PPAR signaling pathway. PPARs are ligand-
activated transcription factors belonging to the nuclear
receptor superfamily of regulatory factors [35]. They ex-
ercise homeostatic functions in the intestine at the inter-
face between nutrient metabolism and immunity, and
their main function is related to the regulation of genes
involved in glucose and lipid metabolism [36,37]. PPAR
family is also involved in the regulation of inflammation
and energy homeostasis [38]. Among them, PPARα directlygoverns the triglyceride hydrolysis pathway in the liver
[39]. CES3 and MGLL are induced in mouse hepatocytes
by short-term treatment with PPARα agonist [40], but the
present result showed down-regulation of CES3 in spite of
up-regulation of PPAR signaling pathway. Further studies
are needed to clarify the relationship between CES3 and
PPAR signaling, but the results suggest that PPAR signal-
ing could be important targets in obesity, obesity-induced
inflammation, and metabolic syndrome.
In the present study, we applied comparative genomic
and proteomic analyses in adipose tissues to identify the
molecular targets associated with obesity related to the
metabolic syndrome. Microarray analysis identified 33
significantly up-regulated genes and 17 significantly down-
regulated genes in the adipose tissues of 6- and 25-week-
old CP, compared with age-matched WKY and Lean rats.
Based on the classification of genes with significant differ-
ence in expression according to their function, a large pro-
portion of the identified genes are known to be involved
in transferase, electron transport, and electron transporter
activity. In KEGG molecular pathway analysis, the up-
regulated genes were involved in PPAR signaling
pathway. The up-regulated proteins identified by pro-
teomics analysis and confirmed by western blot ana-
lysis, CES3 and MGLL were involved in adipose lipolysis
and regulated PPAR signaling. These findings suggest that
the proteins associated with adipocyte lipolysis and PPAR
signaling may be involved in obesity related to the meta-
bolic syndrome.
Additional file
Additional file 1: DNA microarray results. Table S1. Significantly
up-regulated genes in CP rats compared with WKY and Lean rats at 6
and 25 weeks of age. Table S2. Significantly down-regulated genes in CP
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